共 47 条
- [1] Bailey CJ, Biguanides and NIDDM, Diabetes Care, 15, pp. 755-772, (1992)
- [2] Bailey CJ, Metformin: an update, Gen Pharmacol, 24, pp. 1299-1309, (1993)
- [3] Wilcock C, Bailey CJ, Reconsideration of inhibitory effect of metformin on intestinal glucose absorption, J Pharm Pharmacol, 43, pp. 120-121, (1991)
- [4] Penicaud L, Hitier Y, Ferre P, Girard J, Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine, Biochem J, 262, pp. 881-885, (1989)
- [5] Wilcock C, Bailey CJ, Sites of metformin‐stimulated glucose metabolism, Biochem Pharmacol, 39, pp. 1831-1834, (1990)
- [6] Bailey CJ, Wilcock C, Day C, Effect of metformin on glucose metabolism in the splanchnic bed, Br J Pharmacol, 105, pp. 1009-1015, (1992)
- [7] Bailey CJ, Mynett KJ, Page T, Importance of the intestine as a site of metformin‐stimulated glucose utilization, Br J Pharmacol, 112, pp. 671-675, (1994)
- [8] Vidon N, Chaussade S, Noel M, Franchisseur C, Huchet B, Bernier JJ, Metformin in the digestive tract, Diabetes Res Clin Pract, 4, pp. 223-229, (1988)
- [9] Schafer G, Biguanides: a review of histroy, pharmacodynamics and therapy, Diabete Metab, 9, pp. 148-163, (1983)
- [10] Noel M, Kinetic study of normal and sustained release dosage forms of metformin in normal subjects, Res Clin Forums, 1, pp. 35-50, (1979)